MED
MEDIFAST INC
12.20$
+3.9%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +1.2% | +3.3% | +20.4% | +16.1% | +14.9% | +41.8% | +44.3% | -20.6% | -2.0% | -8.3% | -9.6% | |
| – | +7.5% | +15.0% | +23.6% | +16.2% | +5.9% | +52.0% | +31.0% | -27.4% | +0.6% | -4.3% | -5.9% | |
| – | +71.9% | +24.7% | +43.2% | +8.4% | -5.4% | +112.7% | -36.4% | -15.8% | +7.7% | -3.7% | -1.8% | |
| – | +27.5% | +14.5% | +28.6% | +2.2% | -8.3% | +88.3% | -37.2% | -19.9% | +71.1% | +8.2% | +3.0% | |
| – | -1.0% | -15.1% | -58.5% | +75.5% | +42.1% | -59.4% | -100.0% | – | – | – | – | |
| – | -15.3% | +37.3% | +5.6% | +101.2% | +25.4% | +9.5% | +237.2% | -34.0% | -54.1% | -22.3% | -52.3% | |
| – | -13.3% | -32.0% | -5.8% | +6.1% | +31.9% | +6.1% | +103.1% | +1.9% | +17.4% | -27.5% | -21.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -18.9% | -12.3% | +48.2% | +61.5% | +48.9% | +32.3% | +64.8% | -17.7% | -32.7% | -31.7% | -21.6% | |
| – | -12.5% | +3.6% | +52.1% | +62.4% | +31.6% | +40.3% | +52.5% | -17.0% | -34.5% | -30.5% | -33.0% | |
| – | -5.6% | -100.0% | – | – | – | +15.9% | +77.6% | -11.5% | +1.9% | +5.0% | -25.5% | |
| – | -7.5% | -15.0% | +44.0% | +37.8% | +18.9% | +59.6% | +96.4% | -17.2% | -33.2% | -41.2% | -34.6% | |
| – | -100.0% | – | -100.0% | – | – | – | – | – | – | – | – | |
| – | +10.1% | +8.4% | +13.1% | +0.5% | -3.9% | +50.0% | +28.8% | -23.4% | +30.0% | +4.3% | -5.3% | |
| – | +12.3% | +5.5% | +11.0% | +26.6% | +28.5% | -8.6% | +23.3% | -26.5% | +24.9% | +1.2% | -10.5% | |
| – | -5.5% | -1.0% | +1.2% | -0.1% | +0.3% | -2.2% | -0.3% | -4.5% | -3.1% | +0.4% | +0.2% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.